H. R. 2617—1251 
of the House of Representatives may waive the require-
ments of paragraph (1) for the applicable fiscal year with 
respect to the applicable Committee. 
‘‘(B) SCOPE OF REQUIREMENTS.—The requirements of 
this subsection shall not be construed to impact the appear-
ance of other Federal officials or the Director at hearings 
of either Committee described in paragraph (1) at other 
times and for purposes other than the times and purposes 
described in paragraph (1). 
‘‘(3) CLOSED
HEARINGS.—Information that is not appro-
priate for disclosure during an open hearing under paragraph 
(1) in order to protect national security may instead be dis-
cussed in a closed hearing that immediately follows the open 
hearing. 
‘‘(e) OTHER TRANSACTIONS.— 
‘‘(1) IN GENERAL.—In carrying out activities of the Centers 
for Disease Control and Prevention, the Director may enter 
into transactions other than a contract, grant, or cooperative 
agreement for purposes of infectious disease research, bio-
surveillance, infectious disease modeling, and public health 
preparedness and response. 
‘‘(2) WRITTEN DETERMINATION.—With respect to a project 
that is expected to cost the Centers for Disease Control and 
Prevention more than $40,000,000, the Director may exercise 
the authority under paragraph (1) only upon a written deter-
mination by the Assistant Secretary for Financial Resources 
of the Department of Health and Human Services, that the 
use of such authority is essential to promoting the success 
of the project. The authority of the Assistant Secretary for 
Financial Resources under this paragraph may not be dele-
gated. 
‘‘(3) GUIDELINES.—The Director, in consultation with the 
Secretary, shall establish guidelines regarding the use of the 
authority under paragraph (1). Such guidelines shall include 
auditing requirements.’’. 
(b) EFFECTIVE DATE.—The first sentence of section 305(a) of 
the Public Health Service Act, as added by subsection (a), shall 
take effect on January 20, 2025. 
SEC. 2102. ADVISORY COMMITTEE TO THE DIRECTOR OF THE CENTERS 
FOR DISEASE CONTROL AND PREVENTION. 
Title III of the Public Health Service Act (42 U.S.C. 241 et 
seq.) is amended by inserting after section 305, as added by section 
2101, the following: 
‘‘SEC. 305A. ADVISORY COMMITTEE TO THE DIRECTOR. 
‘‘(a) IN GENERAL.—Not later than 60 days after the date of 
the enactment of the PREVENT Pandemics Act, the Secretary, 
acting through the Director of the Centers for Disease Control 
and Prevention (referred to in this section as the ‘Director’), shall 
maintain or establish an advisory committee within the Centers 
for Disease Control and Prevention to advise the Director on policy 
and strategies that enable the agency to fulfill its mission. 
‘‘(b) FUNCTIONS
AND ACTIVITIES.—The Advisory Committee 
may— 
‘‘(1) make recommendations to the Director regarding ways 
to prioritize the activities of the agency in alignment with 
the CDC Strategic Plan required under section 305(c);
H. R. 2617—1252 
‘‘(2) advise on ways to achieve or improve performance 
metrics in relation to the CDC Strategic Plan, and other rel-
evant metrics, as appropriate; 
‘‘(3) provide advice and recommendations on the develop-
ment of the CDC Strategic Plan, and any subsequent updates, 
as appropriate; 
‘‘(4) advise on grants, cooperative agreements, contracts, 
or other transactions, as applicable; 
‘‘(5) provide other advice to the Director, as requested, 
to fulfill duties under sections 301 and 311; and 
‘‘(6) appoint subcommittees. 
‘‘(c) MEMBERSHIP.— 
‘‘(1) IN GENERAL.—The Advisory Committee shall consist 
of not more than 15 non-Federal members, including the Chair, 
to be appointed by the Secretary under paragraph (3). 
‘‘(2) EX OFFICIO MEMBERS.—Any ex officio members of the 
Advisory Council may consist of— 
‘‘(A) the Secretary; 
‘‘(B) the Assistant Secretary for Health; 
‘‘(C) the Director; and 
‘‘(D) such additional officers or employees of the United 
States as the Secretary determines necessary for the 
advisory committee to effectively carry out its functions. 
‘‘(3) APPOINTED MEMBERS.—Individuals shall be appointed 
to the Advisory Committee under paragraph (1) as follows: 
‘‘(A) Twelve of the members shall be appointed by 
the Director from among the leading representatives of 
the health disciplines (including public health, global 
health, health disparities, biomedical research, public 
health preparedness, and other fields, as applicable) rel-
evant to the activities of the agency or center, as applicable. 
‘‘(B) Three of the members may be appointed by the 
Secretary from the general public and may include leaders 
in fields of innovation, public policy, public relations, law, 
economics, or management. 
‘‘(4) COMPENSATION.—Ex officio members of the Advisory 
Council who are officers or employees of the United States 
shall not receive any compensation for service on the advisory 
committee. The remaining members of the advisory committee 
may receive, for each day (including travel time) they are 
engaged in the performance of the functions of the advisory 
committee, compensation at rates not to exceed the daily 
equivalent to the annual rate of basic pay for level III of 
the Executive Schedule under section 5314 of title 5, United 
States Code. 
‘‘(5) TERMS OF OFFICE.— 
‘‘(A) IN
GENERAL.—The term of office of a member 
of the advisory committee appointed under paragraph (3) 
shall be 4 years, except that any member appointed to 
fill a vacancy for an unexpired term shall serve for the 
remainder of such term. The Secretary shall make appoint-
ments to the advisory committee in such a manner as 
to ensure that the terms of the members not all expire 
in the same year. A member of the advisory committee 
may serve after the expiration of such member’s term until 
a successor has been appointed and taken office.
H. R. 2617—1253 
‘‘(B) REAPPOINTMENTS.—A member who has been 
appointed to the advisory committee for a term of 4 years 
may not be reappointed to the advisory committee during 
the 2-year period beginning on the date on which such 
4-year term expired. 
‘‘(C) TIME FOR APPOINTMENT.—If a vacancy occurs in 
the advisory committee among the members appointed 
under paragraph (3), the Secretary shall make an appoint-
ment to fill such vacancy within 90 days from the date 
the vacancy occurs. 
‘‘(d) CHAIR.—The Secretary shall select a member of the 
advisory committee to serve as the Chair of the committee. The 
Secretary may so select an individual from among the appointed 
members. The term of office of the chair shall be 2 years. 
‘‘(e) MEETINGS.—The advisory committee shall meet at the call 
of the Chair or upon request of the Director, but in no event 
less than 2 times during each fiscal year. 
‘‘(f) EXECUTIVE SECRETARY AND STAFF.—The Director shall des-
ignate a member of the staff of the agency to serve as the executive 
secretary of the advisory committee. The Director shall make avail-
able to the advisory committee such staff, information, and other 
assistance as it may require to carry out its functions. The Director 
shall provide orientation and training for new members of the 
advisory committee to provide for their effective participation in 
the functions of the advisory committee.’’. 
SEC. 2103. PUBLIC HEALTH AND MEDICAL PREPAREDNESS AND 
RESPONSE COORDINATION. 
(a) PUBLIC HEALTH EMERGENCY FUND.—Section 319(b) of the 
Public Health Service Act (42 U.S.C. 247d(b)) is amended— 
(1) in paragraph (2)— 
(A) in subparagraph (E), by striking ‘‘and’’ at the end; 
(B) by redesignating subparagraph (F) as subparagraph 
(G); and 
(C) by inserting after subparagraph (E), the following: 
‘‘(F) support the initial deployment and distribution 
of contents of the Strategic National Stockpile, as appro-
priate; and’’; and 
(2) by amending paragraph (3)(A) to read as follows: 
‘‘(A) the expenditures made from the Public Health 
Emergency Fund in such fiscal year, including— 
‘‘(i) the amount obligated; 
‘‘(ii) the recipient or recipients of such obligated 
funds; 
‘‘(iii) the specific response activities such obligated 
funds will support; and 
‘‘(iv) the declared or potential public health emer-
gency for which such funds were obligated; and’’. 
(b) IMPROVING PUBLIC HEALTH AND MEDICAL PREPAREDNESS 
AND RESPONSE COORDINATION.— 
(1) COORDINATION WITH FEDERAL AGENCIES.—Section 2801 
of the Public Health Service Act (42 U.S.C. 300hh) is amended 
by adding at the end the following: 
‘‘(c) COORDINATION WITH FEDERAL AGENCIES.—In leading the 
Federal public health and medical response to a declared or poten-
tial public health emergency, consistent with this section, the Sec-
retary shall coordinate with, and may request support from, other
H. R. 2617—1254 
Federal departments and agencies, as appropriate in order to carry 
out necessary activities and leverage the expertise of such depart-
ments and agencies, which may include the provision of assistance 
at the direction of the Secretary related to supporting the public 
health and medical response for States, localities, and Tribes.’’. 
(2) ASPR DUTIES.—Section 2811(b) of the Public Health 
Service Act (42 U.S.C. 300hh–10(b)) is amended— 
(A) in paragraph (1), by inserting ‘‘and, consistent with 
the National Response Framework and other applicable 
provisions of law, assist the Secretary in carrying out the 
functions under section 2801’’ before the period; and 
(B) in paragraph (4)— 
(i) in subparagraph (E) by striking ‘‘the actions 
necessary to overcome these obstacles.’’ and inserting 
‘‘recommend actions necessary to overcome these 
obstacles, such as— 
‘‘(i) improving coordination with relevant Federal 
officials; 
‘‘(ii) partnering with other public or private entities 
to leverage capabilities maintained by such entities, 
as appropriate and consistent with this subsection; 
and 
‘‘(iii) coordinating efforts to support or establish 
new capabilities, as appropriate.’’; 
(ii) in subparagraph (G)— 
(I) by redesignating clauses (i) and (ii) as sub-
clauses (I) and (II) and adjusting the margins 
accordingly; 
(II) in the matter preceding subclause (I), as 
so redesignated— 
(aa) by inserting ‘‘each year, including 
national-level and State-level full-scale exer-
cises not less than once every 4 years’’ after 
‘‘operational exercises’’; and 
(bb) by striking ‘‘exercises based on—’’ and 
inserting ‘‘exercises— 
‘‘(i) based on’’; 
(III) by striking the period and inserting a 
semicolon; and 
(IV) by adding at the end the following: 
‘‘(ii) that assess the ability of the Strategic 
National Stockpile, as appropriate, to provide medical 
countermeasures, medical products, and other supplies, 
including ancillary medical supplies, to support the 
response to a public health emergency or potential 
public health emergency, including a threat that 
requires the large-scale and simultaneous deployment 
of stockpiles and a long-term public health and medical 
response; and 
‘‘(iii) conducted in coordination with State and local 
health officials.’’; and 
(iii) by adding at the end the following: 
‘‘(J) MEDICAL
PRODUCT
AND
SUPPLY
CAPACITY
PLAN-
NING.—Coordinate efforts within the Department of Health 
and Human Services to support— 
‘‘(i) preparedness for medical product and medical 
supply needs directly related to responding to chemical,